Shannon Kelley
Vermögen: 6 Mio $ am 31.08.2026
Vermögen: 6 Mio $ am 31.08.2026
Shannon Kelley currently works at Madrigal Pharmaceuticals, Inc., as Secretary, Chief Legal Counsel & Executive VP from 2024.
Ms. Kelley also formerly worked at Genzyme Corp., as Chief Compliance Officer-North America.
Ms. Kelley received her graduate degree from American University Washington College of Law and undergraduate degree from Edmund A. Walsh School of Foreign Service.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.08.2026 | 11.474 ( 0,05 % ) | 6 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | General Counsel | 05.08.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Compliance Officer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Edmund A. Walsh School of Foreign Service
Edmund A. Walsh School of Foreign Service Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American University Washington College of Law
American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen